CIK: 0001306923 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $718,352 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CMPX | COMPASS THERAPEUTICS INC | 2,532,419 | $13,599 | 1.9% | $4.62 | 0.0% | COM | 20454B104 |
| ANNX | ANNEXON INC | 2,384,192 | $11,969 | 1.7% | $3.82 | 0.0% | COM | 03589W102 |
| CAPR | CAPRICOR THERAPEUTICS INC | 226,304 | $6,531 | 0.9% | $13.06 | 0.0% | COM NEW | 14070B309 |
| BCAX | BICARA THERAPEUTICS INC | 298,575 | $5,025 | 0.7% | $17.08 | 0.0% | COM | 055477103 |
| XENE | XENON PHARMACEUTICALS INC | 96,519 | $4,326 | 0.6% | $42.00 | 0.0% | COM | 98420N105 |
| INSP | INSPIRE MEDICAL SYSTEMS INC | 8,772 | $809 | 0.1% | $95.68 | 0.0% | COM | 457730109 |
| CMPS | COMPASS PATHWAYS PLC ADR | 115,616 | $798 | 0.1% | $6.90 | — | SPONSORED ADS | 20451W101 |
| — | GENERATION BIO CO | 15,047 | $85 | 0.0% | $5.68 | — | COM | 37148K209 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PTCT | PTC THERAPEUTICS INC | 903,916 (+4.8%) | $68,661 (+29.7%) | 9.6% | $46.25 | +57.1% | COM | 69366J200 |
| ANAB | ANAPTYSBIO INC | 690,032 (+2.5%) | $33,453 (+62.2%) | 4.7% | $19.77 | +97.2% | COM | 032724106 |
| DYN | DYNE THERAPEUTICS INC | 1,472,197 (+16.6%) | $28,796 (+80.3%) | 4.0% | $13.00 | +45.7% | SPONSORED ADS | 26818M108 |
| IRON | DISC MEDICINE INC | 317,456 (+41.5%) | $25,209 (+70.1%) | 3.5% | $61.08 | +38.3% | COM | 254604101 |
| MIRM | MIRUM PHARMACEUTICALS INC | 156,421 (+141.8%) | $12,356 (+160.5%) | 1.7% | $48.52 | +47.9% | COM | 604749101 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 794,507 (+21.3%) | $16,693 (+65.7%) | 2.3% | $15.82 | +10.3% | COM | 87164F105 |
| DNLI | DENALI THERAPEUTICS INC | 641,239 (+57.2%) | $10,587 (+78.7%) | 1.5% | $15.17 | +11.3% | COM | 24823R105 |
| CDNA | CAREDX INC | 478,220 (+51.2%) | $9,010 (+96.0%) | 1.3% | $15.10 | +10.9% | COM | 14167L103 |
| ALKS | ALKERMES PLC | 242,560 (+31.9%) | $6,787 (+23.0%) | 0.9% | $24.20 | +23.8% | COM | G01767105 |
| NVCR | NOVOCURE LTD | 1,298,964 (+3.4%) | $16,796 (+3.5%) | 2.3% | $34.92 | -63.2% | COM | G6674U108 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 461,294 (+24.8%) | $10,610 (-4.5%) | 1.5% | $31.21 | +5.4% | COM | 90400D108 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS INC | 32,320 | $14,738 | 2.1% | $260.36 | +70.0% | — | 02043Q107 |
| RNA | AVIDITY BIOSCIENCES INC | 109,831 | $4,785 | 0.7% | $29.81 | +116.7% | — | 05370A108 |
| — | GENERATION BIO CO | 15,047 | $92 | 0.0% | $2.82 | — | — | 37148K100 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| FOLD | AMICUS THERAPEUTICS INC | 5,205,767 (-3.0%) | $74,130 (+75.3%) | 10.3% | $9.63 | +2.1% | COM | 03152W109 |
| BIIB | BIOGEN INC | 183,571 (-1.1%) | $32,307 (+24.2%) | 4.5% | $256.18 | -36.2% | SPONSORED ADS | 09062X103 |
| AGIO | AGIOS PHARMACEUTICALS INC | 212,499 (-20.0%) | $5,784 (-45.7%) | 0.8% | $33.17 | +5.8% | COM | 00847X104 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 746,256 (-1.0%) | $44,350 (+8.6%) | 6.2% | $83.16 | -34.5% | COM | 09061G101 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 7,116,676 (-6.6%) | $19,429 (+17.5%) | 2.7% | $4.09 | -43.4% | COM NEW | 462260100 |
| TSHA | TAYSHA GENE THERAPIES INC | 1,183,195 (-5.0%) | $6,508 (+59.7%) | 0.9% | $1.87 | +159.1% | COM | 877619106 |
| NUVB | NUVATION BIO INC | 538,079 (-47.3%) | $4,821 (+27.7%) | 0.7% | $2.12 | +192.8% | COM CL A | 67080N101 |
| ALGN | ALIGN TECHNOLOGY INC | 41,520 (-9.2%) | $6,483 (+13.2%) | 0.9% | $150.48 | -4.8% | COM | 016255101 |
| GOSS | GOSSAMER BIO INC | 4,471,592 (-18.2%) | $13,862 (-3.5%) | 1.9% | $1.58 | +80.7% | COM | 38341P102 |
| STOK | STOKE THERAPEUTICS INC | 72,022 (-31.7%) | $2,286 (-7.7%) | 0.3% | $6.06 | +396.2% | COM | 86150R107 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INSM | INSMED INC | 489,482 | $85,189 | 11.9% | $17.79 | +925.7% | COM | 457669307 |
| ACAD | ACADIA PHARMACEUTICALS INC | 2,484,031 | $66,348 | 9.2% | $26.96 | -11.4% | COM | 004225108 |
| UTHR | UNITED THERAPEUTICS CORP | 58,186 | $28,351 | 3.9% | $89.23 | +421.9% | COM | 91307C102 |
| ACRS | ACLARIS THERAPEUTICS INC | 1,566,840 | $4,716 | 0.7% | $1.44 | +75.3% | COM | 00461U105 |
| TVTX | TRAVERE THERAPEUTICS INC | 110,719 | $4,231 | 0.6% | $23.56 | +38.0% | COM SHS | 89422G107 |
| PYXS | PYXIS ONCOLOGY INC | 1,037,421 | $1,193 | 0.2% | $2.98 | +18.2% | COM | 747324101 |
| ORKA | ORUKA THERAPEUTICS INC | 59,985 | $1,818 | 0.3% | $14.82 | +88.0% | COM | 687604108 |
| CRSP | CRISPR THERAPEUTICS AG | 41,226 | $2,162 | 0.3% | $38.70 | +54.8% | NAMEN AKT | H17182108 |
| EHTH | EHEALTH INC | 1,531,429 | $7,045 | 1.0% | $38.13 | -88.4% | COM | 28238P109 |
| PRTA | PROTHENA CORP PLC | 1,320,510 | $12,611 | 1.8% | $20.95 | -51.4% | COM CL A | G72800108 |
| EW | EDWARDS LIFESCIENCES CORP | 33,640 | $2,868 | 0.4% | $72.66 | +13.0% | COM | 28176E108 |
| BCYC | BICYCLE THERAPEUTICS PLC-ADR | 221,071 | $1,565 | 0.2% | $16.07 | — | COM | 088786108 |
| AKTX | AKARI THERAPEUTICS PLC-ADR | 146,024 | $42 | 0.0% | $1.22 | — | COM | 00972G207 |
| URGN | UROGEN PHARMA LTD | 24,500 | $574 | 0.1% | $27.01 | -19.7% | COM | M96088105 |
| BNTX | BIONTECH SE-ADR | 19,614 | $1,867 | 0.3% | $118.77 | — | COM | 09075V102 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 18,117 | $2,570 | 0.4% | $129.01 | +12.3% | COM | 64125C109 |
| PRQR | PROQR THERAPEUTICS NV | 188,807 | $381 | 0.1% | $2.18 | +7.0% | SHS EURO | N71542109 |
| HUM | HUMANA INC | 3,985 | $1,021 | 0.1% | $369.63 | -29.3% | COM | 444859102 |
| ALDX | ALDEYRA THERAPEUTICS INC | 225,465 | $1,168 | 0.2% | $5.95 | -13.6% | SPONSORED ADR | 01438T106 |
| ABEO | ABEONA THERAPEUTICS INC | 108,865 | $574 | 0.1% | $6.04 | -16.7% | COM NEW | 00289Y206 |